Pages that link to "Q46052772"
Jump to navigation
Jump to search
The following pages link to Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety (Q46052772):
Displaying 21 items.
- Structure-based discovery of opioid analgesics with reduced side effects (Q26331003) (← links)
- Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level (Q27348715) (← links)
- Dopamine receptors - IUPHAR Review 13 (Q28256783) (← links)
- Structure-guided development of heterodimer-selective GPCR ligands (Q28828634) (← links)
- Comparative MD Simulations Indicate a Dual Role for Arg1323.50 in Dopamine-Dependent D2R Activation (Q35887927) (← links)
- Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis (Q35892818) (← links)
- High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice. (Q37077658) (← links)
- Recent molecular approaches to understanding astrocyte function in vivo (Q37412106) (← links)
- Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database (Q42317202) (← links)
- Structure-based evolution of subtype-selective neurotensin receptor ligands (Q43009099) (← links)
- Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists (Q46800555) (← links)
- Bioluminescence Resonance Energy Transfer Assay to Characterize Gi-Like G Protein Subtype-Dependent Functional Selectivity. (Q47616908) (← links)
- A kinetic view of GPCR allostery and biased agonism (Q47935295) (← links)
- In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease. (Q52665081) (← links)
- Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. (Q52668422) (← links)
- Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease. (Q64901815) (← links)
- A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity (Q89531733) (← links)
- Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists (Q92388074) (← links)
- Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity (Q92455368) (← links)
- D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine (Q92968450) (← links)
- Fluorescent ligands for dopamine D<sub>2</sub>/D<sub>3</sub> receptors (Q104471881) (← links)